Saturday 17 October 2026 Export RARE’s income statement to Excel — free account

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc.’s revenue for fiscal 2025 (year ended December 2025) was $673.0 million, up 20.2% from fiscal 2024. In the quarter to June 2026, revenue grew 28.1%, EPS grew 23.1% and free cash flow grew 12.5%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

14.54 0.63 −4.15%

Follow RARE

Alert me

Market cap: $1.5B
P/E: 0.0×
Fwd P/E: −4.8×
Dividend yield: —
F-score: 5/9
Altman Z: −3.57
Beneish M: −2.68
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	838.86%	1,327.47%	(657.14%)	(325.64%)	+8 more TTM periods Free account
Piotroski F-Score Full definition →	3	3	5	3
ROA Full definition →	(45.60%)	(46.70%)	(37.89%)	(42.48%)
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	(119.59%)	(106.65%)	(70.90%)	(104.79%)
Average Days of Receivables Full definition →	101.81	65.92	85.69	65.14
Free Cash Flow per Share Full definition →	(4.85)	(5.05)	(4.94)	(4.67)
Free Cash Flow Full definition →	(494.00)	(508.00)	(487.00)	(466.21)
Capital Expenditures Full definition →	(9.00)	(11.00)	(21.00)	(20.72)
Other line items
Cash ROIC Full definition →	(49,400.00%)	(287.01%)	(81.17%)	(107.32%)
Accounts Receivable Turnover Full definition →	4.42	6.10	4.81	6.13
Accounts Payable Turnover Full definition →	3.30	2.46	3.11	2.54
Inventory Turnover Full definition →	2.29	2.18	2.25	2.03
Average Days of Payables Full definition →	117.64	139.36	103.81	152.42
Days of Inventory on Hand Full definition →	177.98	182.50	174.13	196.11
Tax Rate Full definition →	0.01	0.01	0.01	0.01
Research and Development Expense of Revenue Full definition →	107.81%	115.07%	111.44%	116.58%
Selling, General and Administrative Expense of Revenue Full definition →	48.95%	52.24%	51.86%	54.32%
Share Based Compensation of Revenue Full definition →	19.39%	21.34%	22.73%	24.71%
Interest Coverage Full definition →	(6.86)	(8.13)	(8.63)	(9.44)
Operating CF/Net income Full definition →	0.83	0.82	0.81	0.77
Depreciation/Fixed assets Full definition →	0.13	0.13	0.13	0.12
Capex/Depreciation Full definition →	(0.29)	(0.35)	(0.68)	(0.71)
Revenue per Share Full definition →	7.04	6.66	6.83	6.32
Operating CF per Share Full definition →	(4.76)	(4.94)	(4.73)	(4.47)
Capex per Share Full definition →	(0.09)	(0.11)	(0.21)	(0.21)
Capex to Sales Full definition →	0.01	0.02	0.03	0.03

Fold the line items

Columns are period end dates

Stockrow Weekly